首页 / 院系成果 / 成果详情页

Use of Next Generation Sequencing and Synergy Susceptibility Testing in Diagnosis and Treatment of Carbapenem-Resistant Klebsiella pneumoniae Blood Stream Infection 期刊论文

编号：

10c4168b-62f8-4524-ad50-9370c3e6a74d
作者：

Yu, Yuetian^[1];Hu, Fupin(胡付品)^[2]Zhu, Cheng^[3];Chen, Erzhen^[3];Lu, Liangjing^[4];Gao, Yuan^[1];
语种：

English
期刊：

CASE REPORTS IN INFECTIOUS DISEASES ISSN：2090-6625 2018 年
收录：
摘要：

Early diagnosis and appropriate treatment for carbapenem-resistant Klebsiella pneumoniae (CR-Kp) infection is a big challenge for clinicians due to its high mortality. Every effort has been made to improve its clinical outcomes. However, treatment according to synergy susceptibility testing has never been reported in the literature. We reported a 29-year-old systemic lupus erythematosus female with CR-Kp blood stream infection. We highlighted the identification by next generation sequencing and treatment according to synergy susceptibility testing in the case.
推荐引用方式
GB/T 7714：

Yu Yuetian,Hu Fupin,Zhu Cheng, et al. Use of Next Generation Sequencing and Synergy Susceptibility Testing in Diagnosis and Treatment of Carbapenem-Resistant Klebsiella pneumoniae Blood Stream Infection [J].CASE REPORTS IN INFECTIOUS DISEASES,2018.
APA：

Yu Yuetian,Hu Fupin,Zhu Cheng,Chen Erzhen,&Gao Yuan.(2018).Use of Next Generation Sequencing and Synergy Susceptibility Testing in Diagnosis and Treatment of Carbapenem-Resistant Klebsiella pneumoniae Blood Stream Infection .CASE REPORTS IN INFECTIOUS DISEASES.
MLA：

Yu Yuetian, et al. "Use of Next Generation Sequencing and Synergy Susceptibility Testing in Diagnosis and Treatment of Carbapenem-Resistant Klebsiella pneumoniae Blood Stream Infection" .CASE REPORTS IN INFECTIOUS DISEASES(2018).

浏览次数：4  下载次数：0

分享到：

浏览次数：4

下载次数：0

打印次数：0